Found: 20
Select item for more details and to access through your institution.
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 720, doi. 10.1002/ajh.26866
- By:
- Publication type:
- Article
Daratumumab, lenalidomide, and dexamethasone in systemic light‐chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E253, doi. 10.1002/ajh.26191
- By:
- Publication type:
- Article
Comparison of IGLV2‐14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
- Published in:
- FEBS Journal, 2023, v. 290, n. 17, p. 4256, doi. 10.1111/febs.16805
- By:
- Publication type:
- Article
Prognosis and Staging of AL Amyloidosis.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 4, p. 388, doi. 10.1159/000508287
- By:
- Publication type:
- Article
Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement.
- Published in:
- PLoS ONE, 2022, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0264407
- By:
- Publication type:
- Article
Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 5, p. 799, doi. 10.1002/acn3.51049
- By:
- Publication type:
- Article
Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.
- Published in:
- 2018
- By:
- Publication type:
- journal article
AL amyloidosis with a localized B cell neoplasia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-09032-0
- By:
- Publication type:
- Article
HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients.
- Published in:
- EJHaem, 2024, v. 5, n. 4, p. 815, doi. 10.1002/jha2.918
- By:
- Publication type:
- Article
Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior—A case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 7, p. 1464, doi. 10.1002/cam4.725
- By:
- Publication type:
- Article
Submyeloablative total body irradiation‐based conditioning and allogeneic stem cell transplantation in high‐risk myeloma with early progression after up‐front autologous transplantation.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 244, doi. 10.1111/bjh.17779
- By:
- Publication type:
- Article
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow‐up.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 230, doi. 10.1111/bjh.17685
- By:
- Publication type:
- Article
Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26553-9
- By:
- Publication type:
- Article
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49520-6
- By:
- Publication type:
- Article
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2257, doi. 10.3390/jcm13082257
- By:
- Publication type:
- Article
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2087, doi. 10.1007/s00277-020-04362-2
- By:
- Publication type:
- Article
A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
- Published in:
- Clinical Research in Cardiology, 2020, v. 109, n. 6, p. 700, doi. 10.1007/s00392-019-01559-y
- By:
- Publication type:
- Article